• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

E2F-1转录因子的氨基末端抑制哺乳动物细胞中自主复制质粒的DNA复制。

The amino-terminus of the E2F-1 transcription factor inhibits DNA replication of autonomously replicating plasmids in mammalian cells.

作者信息

Stubbs Matthew C, Hall David J

机构信息

Cartilage and Orthopaedic Branch, National Institutes of Arthritis and Musculoskeletal and Skin Diseases, NIH, MSC 5755, 9000 Rockville Pike, Bethesda, Maryland, MD 20892, USA.

出版信息

Oncogene. 2002 May 23;21(23):3715-26. doi: 10.1038/sj.onc.1205473.

DOI:10.1038/sj.onc.1205473
PMID:12032840
Abstract

The E2F1 transcription factor plays a pivotal role in driving cells out of a quiescent state and into the S phase of the cell cycle, in part by transactivating genes needed for DNA replication including DHFR, thymidine kinase, and DNA Polymerase alpha. E2F1 has also been implicated in regulating an S phase checkpoint, however its role in this checkpoint is not well defined. To determine how E2F1 affects such a checkpoint, we utilized an in vivo replication assay employing a plasmid based SV40 origin of replication, transfected into cells expressing SV40 large T antigen. Here we show that expression of full length E2F1, or only its N terminus, represses replication from plasmids containing the SV40 origin, while N terminal deletions of E2F1 do not. E2F1 appears to inhibit the elongation phase of replication and not the initiation phase since it does not affect the replication of other cotransfected plasmids containing only the SV40 origin. Further, inhibition of replication is dependent on both the amino-terminus of the E2F1 protein and on a DNA sequence that is contained within the 3' end of the E2F1 cDNA. Additionally, both full-length E2F1, or just its N-terminus, form protein complexes with two portions of the 3' end of the E2F1 cDNA. These data provide a clue to the mechanism by which E2F1 regulates transit through the S phase checkpoint, by acting on a specific DNA sequence via its amino-terminal region, to inhibit elongation of DNA replication.

摘要

E2F1转录因子在驱动细胞脱离静止状态并进入细胞周期的S期过程中发挥着关键作用,部分原因是它能反式激活DNA复制所需的基因,包括二氢叶酸还原酶(DHFR)、胸苷激酶和DNA聚合酶α。E2F1也被认为参与调节S期检查点,然而其在该检查点中的作用尚未明确界定。为了确定E2F1如何影响这样一个检查点,我们利用了一种体内复制测定法,该方法采用基于质粒的SV40复制起点,将其转染到表达SV40大T抗原的细胞中。在这里我们表明,全长E2F1的表达,或仅其N末端的表达,会抑制含有SV40起点的质粒的复制,而E2F1的N末端缺失则不会。E2F1似乎抑制复制的延伸阶段而非起始阶段,因为它不影响其他仅含有SV40起点的共转染质粒的复制。此外,复制的抑制既依赖于E2F1蛋白的氨基末端,也依赖于E2F1 cDNA 3'端所含的一个DNA序列。另外,全长E2F1或仅其N末端,都会与E2F1 cDNA 3'端的两个部分形成蛋白质复合物。这些数据为E2F1通过其氨基末端区域作用于特定DNA序列来抑制DNA复制延伸从而调节通过S期检查点的机制提供了线索。

相似文献

1
The amino-terminus of the E2F-1 transcription factor inhibits DNA replication of autonomously replicating plasmids in mammalian cells.E2F-1转录因子的氨基末端抑制哺乳动物细胞中自主复制质粒的DNA复制。
Oncogene. 2002 May 23;21(23):3715-26. doi: 10.1038/sj.onc.1205473.
2
Isolation of two novel cDNAs whose products associate with the amino terminus of the E2F1 transcription factor.两个新的cDNA的分离,其产物与E2F1转录因子的氨基末端相关联。
Biochemistry. 1996 Sep 24;35(38):12320-8. doi: 10.1021/bi9611927.
3
An early S phase checkpoint is regulated by the E2F1 transcription factor.早期S期检查点由E2F1转录因子调控。
Biochem Biophys Res Commun. 1999 Apr 29;258(1):77-80. doi: 10.1006/bbrc.1999.0603.
4
Distinct recruitment of E2F family members to specific E2F-binding sites mediates activation and repression of the E2F1 promoter.E2F家族成员特异性募集至特定E2F结合位点介导E2F1启动子的激活与抑制。
Oncogene. 2003 Oct 23;22(48):7632-41. doi: 10.1038/sj.onc.1206840.
5
Transcriptional regulation of the mouse PNRC2 promoter by the nuclear factor Y (NFY) and E2F1.核因子Y(NFY)和E2F1对小鼠PNRC2启动子的转录调控。
Gene. 2005 Nov 21;361:89-100. doi: 10.1016/j.gene.2005.07.012. Epub 2005 Sep 21.
6
PARP-1 binds E2F-1 independently of its DNA binding and catalytic domains, and acts as a novel coactivator of E2F-1-mediated transcription during re-entry of quiescent cells into S phase.PARP-1独立于其DNA结合域和催化域与E2F-1结合,并在静止细胞重新进入S期期间作为E2F-1介导转录的新型共激活因子发挥作用。
Oncogene. 2003 Nov 20;22(52):8460-71. doi: 10.1038/sj.onc.1206897.
7
Expression analysis using DNA microarrays demonstrates that E2F-1 up-regulates expression of DNA replication genes including replication protein A2.使用DNA微阵列进行的表达分析表明,E2F-1上调包括复制蛋白A2在内的DNA复制基因的表达。
Oncogene. 2001 Mar 15;20(11):1379-87. doi: 10.1038/sj.onc.1204230.
8
Efficient replication of plasmids containing the SV40 origin in N-myc overexpressing human neuroblastoma cells.含有SV40复制起点的质粒在过表达N-myc的人神经母细胞瘤细胞中的高效复制。
Oncogene. 1991 Jul;6(7):1161-9.
9
Reduction in fibronectin expression and alteration in cell morphology are coincident in NIH3T3 cells expressing a mutant E2F1 transcription factor.
Exp Cell Res. 1997 Nov 1;236(2):527-36. doi: 10.1006/excr.1997.3762.
10
Expression of MCM10 and TopBP1 is regulated by cell proliferation and UV irradiation via the E2F transcription factor.MCM10和TopBP1的表达受细胞增殖和紫外线照射通过E2F转录因子调控。
Oncogene. 2004 Aug 19;23(37):6250-60. doi: 10.1038/sj.onc.1207829.

引用本文的文献

1
Mapping Single-Cell Transcriptomes of Endometrium Reveals Potential Biomarkers in Endometrial Cancer.子宫内膜单细胞转录组图谱揭示子宫内膜癌潜在生物标志物
Immunotargets Ther. 2024 Jul 16;13:349-366. doi: 10.2147/ITT.S470994. eCollection 2024.
2
S-phase-coupled apoptosis in tumor suppression.肿瘤抑制中的 S 期偶联凋亡。
Cell Mol Life Sci. 2011 Jun;68(11):1883-96. doi: 10.1007/s00018-011-0666-x. Epub 2011 Mar 25.
3
The E8--E2 gene product of human papillomavirus type 16 represses early transcription and replication but is dispensable for viral plasmid persistence in keratinocytes.
人乳头瘤病毒16型的E8-E2基因产物可抑制早期转录和复制,但对于病毒质粒在角质形成细胞中的持续存在并非必需。
J Virol. 2008 Nov;82(21):10841-53. doi: 10.1128/JVI.01481-08. Epub 2008 Aug 27.
4
Enhanced expression of 70-kilodalton heat shock protein limits cell division in a sepsis-induced model of acute respiratory distress syndrome.70千道尔顿热休克蛋白的表达增强限制了脓毒症诱导的急性呼吸窘迫综合征模型中的细胞分裂。
Crit Care Med. 2008 Jan;36(1):246-55. doi: 10.1097/01.CCM.0000295473.56522.EF.